97 related articles for article (PubMed ID: 3898288)
1. Safety of thymopentin. Data from European clinical studies.
Weiss P; Stocker H
Surv Immunol Res; 1985; 4 Suppl 1():149-54. PubMed ID: 3898288
[TBL] [Abstract][Full Text] [Related]
2. Thymopentin in active rheumatoid arthritis. An open, monitored study in 16 patients.
Franchimont P; Hauwaert C; Bolla K
Surv Immunol Res; 1985; 4 Suppl 1():81-6. PubMed ID: 3898297
[TBL] [Abstract][Full Text] [Related]
3. Thymopentin: safety overview.
Friedmann N
Surv Immunol Res; 1985; 4 Suppl 1():139-48. PubMed ID: 3898287
[TBL] [Abstract][Full Text] [Related]
4. Interim results on the clinical effects of i.v. administered thymopentin in active rheumatoid arthritis.
Malaise M; Franchimont P; Hauwaert C; Danneskiold-Samsoe B; Gross D; Gerber H; Gerschpacher H; Bolla K
Int J Clin Pharmacol Res; 1984; 4(6):451-7. PubMed ID: 6398314
[TBL] [Abstract][Full Text] [Related]
5. [Immunomodulating therapy in chronic polyarthritis with thymopentin. A multicenter placebo-controlled study of 119 patients].
Lemmel EM; Bach GL; Bolten W; Brackertz D; Fahmy Z; Mattern H; Stroehmann I; Wittenborg A
Dtsch Med Wochenschr; 1988 Feb; 113(5):172-6. PubMed ID: 3276492
[TBL] [Abstract][Full Text] [Related]
6. Thymopoietin pentapeptide (thymopentin, TP-5) in the treatment of rheumatoid arthritis. A compilation of several short- and longterm clinical studies.
Veys EM; Mielants H; Verbruggen G; Spiro T; Newdeck E; Power D; Goldstein G
J Rheumatol; 1984 Aug; 11(4):462-6. PubMed ID: 6384507
[TBL] [Abstract][Full Text] [Related]
7. Thymopentin (TP-5) in the treatment of rheumatoid arthritis.
Kantharia BK; Goulding NJ; Hall ND; Davies J; Maddison PJ; Bacon PA; Farr M; Wojtulewski JA; Englehart KM; Liyanage SP
Br J Rheumatol; 1989 Apr; 28(2):118-23. PubMed ID: 2650797
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy and tolerability of thymopoietin in patients at risk of infection].
Recenti Prog Med; 1987; 78(7-8):358-64. PubMed ID: 3321257
[No Abstract] [Full Text] [Related]
9. Confirmative study of the effectiveness of thymopentin in active rheumatoid arthritis.
Malaise M; Franchimont P; Hauwaert C; Danneskiold-Samsoe B; Gross D; Gerber H; Gerschpacher H; Bolla K
Surv Immunol Res; 1985; 4 Suppl 1():87-93. PubMed ID: 3898298
[TBL] [Abstract][Full Text] [Related]
10. First observations on high-dosed and long-term thymopentin treatment in active rheumatoid arthritis.
Molin L; Schmid F; Bolla K
Int J Clin Pharmacol Res; 1984; 4(6):445-9. PubMed ID: 6398313
[TBL] [Abstract][Full Text] [Related]
11. [Telethermographic evaluation of the intra-articular administration of thymopentin in rheumatoid arthritis of the knee].
Pappalardo A; Sallì L; Campisi D; Scalici G; Di Marco C; Martorana U
Clin Ter; 1989 Mar; 128(5):321-7. PubMed ID: 2524320
[TBL] [Abstract][Full Text] [Related]
12. Some observations on various dose regimens of thymopentin treatment in rheumatoid arthritis.
Molin L; Schmid F; Bolla K
Surv Immunol Res; 1985; 4 Suppl 1():76-80. PubMed ID: 3898296
[TBL] [Abstract][Full Text] [Related]
13. Thymopentin treatment in genital warts of long duration.
Fransen L; Anthoons J; Hoogewijs G; Bolla K
Cancer Detect Prev; 1988; 12(1-6):503-9. PubMed ID: 3052838
[TBL] [Abstract][Full Text] [Related]
14. Rationale for thymopentin as therapeutic agent in rheumatoid arthritis.
Franchimont P; Bolla K
Surv Immunol Res; 1985; 4 Suppl 1():70-5. PubMed ID: 3898295
[TBL] [Abstract][Full Text] [Related]
15. [A case of juvenile rheumatoid arthritis treated with thymopentin].
Tucciarone L; Felici W; Greco L; Mechelli A
Minerva Pediatr; 1989 Feb; 41(2):109-11. PubMed ID: 2661988
[TBL] [Abstract][Full Text] [Related]
16. Thymopentin in chronic Trichophyton rubrum infection.
Molin L; Bolla K
Surv Immunol Res; 1985; 4 Suppl 1():135-8. PubMed ID: 3898286
[TBL] [Abstract][Full Text] [Related]
17. Effect of thymopoietin pentapeptide on low reversible E-rosette forming cells of rheumatoid arthritis patients. -I) In vitro study.
Auteri A; Laghi Pasini F; Pasqui AL; Bilenchi R; Di Perri T
Boll Soc Ital Biol Sper; 1980 Feb; 56(4):308-11. PubMed ID: 7018514
[No Abstract] [Full Text] [Related]
18. Thymopentin in experimental and clinical medicine.
Surv Immunol Res; 1985; 4 Suppl 1():1-156. PubMed ID: 3898279
[No Abstract] [Full Text] [Related]
19. Clinical response to therapy with thymopoietin pentapeptide (TP-5) in rheumatoid arthritis.
Veys EM; Huskisson EC; Rosenthal M; Vischer TL; Mielants H; Thrower PA; Scott J; Ott H; Scheijgrond H; Symoens J
Ann Rheum Dis; 1982 Oct; 41(5):441-3. PubMed ID: 6751241
[TBL] [Abstract][Full Text] [Related]
20. The effect of thymopentin treatment on the relapse rate in frequently relapsing herpes simplex virus infections.
Haneke E; Bolla K; Degreef H; Djawari D; Demaubeuge J; Molin L; Panconesi E; Schöpf E; Stengel R; Stingl G
Int J Clin Pharmacol Res; 1984; 4(6):439-43. PubMed ID: 6085327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
